香港股市 已收市

靈康藥業 (603669.SS)

Shanghai - Shanghai 延遲價格。貨幣為 CNY。
加入追蹤清單
4.7300+0.1000 (+2.16%)
收市:03:00PM CST

靈康藥業

Commercial and Residential Building 2
1st Floor No. 68, Naidong Road Naidong County, Zedong Town
Shannan 856000
China
86 89 8783 0666
https://www.lingkang.com.cn

版塊Healthcare
行業Drug Manufacturers - Specialty & Generic
全職員工475

高階主管

名稱頭銜支付行使價出生年份
Ms. Ling Ping TaoGM & Chairman of the Board1970
Mr. Jun Ke ZhangAccounting Supervisor, Financial Director & Secretary of the Board of Directors1986
Mr. Xiao Gang TaoDeputy GM & Director1976
Mr. Jun LuDeputy GM & Director1975
截止 為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 CNY。

描述

Lionco Pharmaceutical Group Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells pharmaceuticals in China. The company offers nutrition, antimicrobial, antiviral, digestion, cardiovascular, detoxification, anti-tumor, and other products. Lionco Pharmaceutical Group Co., Ltd. was founded in 2003 and is based in Shannan, China.

公司管治

截至 無 止,靈康藥業 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中:無;董事會:無;股東權利:無;現金賠償:無。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。